Anaxomics Biotech SL

Anaxomics Biotech SL is an SME in Barcelona, Spain that has taken part in 24 EU-funded projects since 2009, receiving €6.4M in EU funding.

EU funding received€6.4M
EU projects24
As coordinator0
Running now3
First EU project2009
Latest project2024
CountrySpain
EU registration (PIC)998152505
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Anaxomics Biotech SL's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€3.8M · 9 projects
  • Horizon 2020€2.7M · 12 projects
  • Horizon Europe€18k · 3 projects

Projects

24 EU-funded projects, newest first. Each links to the official record.

  • CarrerasPathfindersAssociated partner

    Enabling the next generation in search of blood cancer cures

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

  • CarrerasLeadersAssociated partner

    Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • halt-RONINPartner

    Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €18ktheir share
  • PROTrEINPartner

    Computational Proteomics Training European Innovative Network

    Horizon 2020 · 2021–2024 · Project on CORDIS ↗

    €251ktheir share
  • RECOGNISEDPartner

    Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €71ktheir share
  • SMA-TBPartner

    A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients.

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €428ktheir share
  • DISCOvERIEPartner

    Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in iRritable bowel syndrome In Europe

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €167ktheir share
  • SECRETPartner

    Exploitation of the SECRETory pathway for cancer therapy to address European research

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €251ktheir share
  • proEVLifeCyclePartner

    The life cycle of extracellular vesicles in prostate cancer: from biogenesis and homing, to functional relevance

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €251ktheir share
  • HELICALPartner

    HEalth data LInkage for ClinicAL benefit

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €251ktheir share
  • LEGACyPartner

    CeLac and European consortium for a personalized medicine approach to Gastric Cancer

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €275ktheir share
  • COSMICPartner

    COmbatting disorders of adaptive immunity with Systems MedICine

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €248ktheir share
  • DRIVEPartner

    Driving next generation autophagy researchers towards translation

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €248ktheir share
  • TREATMENTPartner

    Training European Network: Metabolic Dysfunctions associated with Pharmacological Treatment of Schizophrenia

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

  • LIVERHOPEPartner

    SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS

    Horizon 2020 · 2017–2023 · Project on CORDIS ↗

    €224ktheir share
  • INDOXPartner

    Optimized oxidoreductases for medium and large scale industrial biotransformations

    FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗

    €349ktheir share
  • TRIGGERPartner

    King of hearts, joints and lungs; periodontal pathogens as etiologic factor in RA, CVD and COPD and their impact on treatment strategies

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €300ktheir share
  • COMBIMSPartner

    A novel drug discovery method based on systems biology: combination therapy and biomarkers for Multiple Sclerosis

    FP7 (2007 to 2013) · 2013–2014 · Project on CORDIS ↗

    €299ktheir share
  • SYSMALVACPartner

    Identifying correlates of protection to accelerate vaccine trials: systems evaluation of two models of experimentally-induced immunity to malaria

    FP7 (2007 to 2013) · 2013–2014 · Project on CORDIS ↗

    €295ktheir share
  • SYSTEMAGEPartner

    Early warning signals of ageing in human stem cells and age-related disorders

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €1.4Mtheir share
  • VISIONPartner

    Prolonged inhibition of semaphorine3a pathway via a bio-degradable implant towards a better therapy for visual sensory impairments

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €466ktheir share
  • RAPIDPartner

    Rheumatoid Arthritis and Periodontal Inflammatory Disease (RAPID)

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €228ktheir share
  • GUMS AND JOINTSPartner

    Protein citrullination as a link between periodontal diseases and rheumatoid arthritis (RA) and target for development of novel drugs to treat RA

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €161ktheir share
  • ANTIPATHOGNPartner

    Identification and validation of novel drug targets in Gram-negative bacteria by global search: a trans-system approach

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €232ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • autoimmune diseases
  • bacteriology
  • biocatalysis
  • biochemistry
  • cardiovascular diseases
  • cell biology
  • cell polarity
  • clinical microbiology
  • colorectal cancer
  • data protection
  • data science
  • databases
  • diabetes
  • drug discovery

Anaxomics Biotech SL is listed on EUACC

See the startup profile for its product, team and what it is looking for.

Open the startup profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime